MANAGEMENT OF PERIOPERATIVE PAIN IN ANTERIOR CRUCIATE LIGAMENT SURGERY PATIENTS RECEIVING OXYCODONE, GABAPENTIN, NSAID AND PLACEBO: CLINICAL TRIAL STUDY

Main Article Content

Ramin Abrishami
Seyed Hadi Aghili
Cyrus Afshar
Mehri Farhang Ranjbar
Ibrahim Mohammadzadeh
Farzin Dehghani Mahmoodabadi

Keywords

Perioperative pain, Anterior Cruciate Ligament Surgery, oxycodone, Gabapentin. NSAIDs, Placebo, Postoperative pain

Abstract

Anterior cruciate ligament reconstructions (ACLR) are a common orthopedic sports medicine procedure, with around 130,000 arthroscopic cases annually, mostly performed on an outpatient basis. While ACLR boasts success rates of up to 95%, postoperative pain remains a significant obstacle to timely patient discharge, leading to prolonged care and increased costs. Despite its prevalence and high success rates, there is a lack of consensus and clear protocols regarding the most effective perioperative pain management strategies. This parallel clinical trial involved 200 participants undergoing ACL surgery, randomly assigned to receive placebo, oxycodone, gabapentin, or NSAIDs one hour prior to surgery. Pain levels were assessed using the Visual Analog Scale (VAS) at various post-operative time intervals, and pethidine usage was recorded. Findings indicated gender-based discrepancies in post-operative pain, with females experiencing higher intensity, particularly at three and 6hours post-surgery. Oxycodone demonstrated superior immediate relief, while placebo recipients were more likely to seek additional pain relief, indicating perceived ineffectiveness. The study emphasizes the evolving nature of post-operative pain and underscores the necessity for effective long-term pain management strategies, offering significant insights for optimizing pain relief approaches in ACL surgery patients

Abstract 347 | pdf Downloads 168

References

1. Wilcox, C.M., B. Cryer, and G. Triadafilopoulos, Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. The Journal of rheumatology, 2005. 32(11): p. 2218-2224.
2. Srebro, Z., et al., Aspirin augments the concentration of endogenous hydrogen sulfide in mouse brain and liver. Folia Med Cracov, 2006. 47: p. 87-91.
3. Brune, K. and P. Patrignani, New insights into the use of currently available non-steroidal anti-inflammatory drugs. Journal of pain research, 2015: p. 105-118.
4. Kutlu Yalcin, E., J. Araujo-Duran, and A. Turan, Emerging drugs for the treatment of postsurgical pain. Expert Opinion on Emerging Drugs, 2021. 26(4): p. 371-384.
5. Motola, D., et al., Pattern of NSAID use in the Italian general population: a questionnaire-based survey. European journal of clinical pharmacology, 2004. 60: p. 731-738.
6. Hernández-Díaz, S. and L.A.G. Rodríguez, Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Archives of internal medicine, 2000. 160(14): p. 2093-2099.
7. Friedlander, E.B., et al., Prophylactic pregabalin to decrease pain during medication abortion: a randomized controlled trial. Obstetrics and gynecology, 2018. 132(3): p. 612.
8. Kyle, M.E., J.C. Wang, and J.J. Shin, Impact of nonaspirin nonsteroidal anti-inflammatory agents and acetaminophen on sensorineural hearing loss: a systematic review. Otolaryngology–Head and Neck Surgery, 2015. 152(3): p. 393-409.
9. Ungprasert, P., et al., Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. European journal of internal medicine, 2015. 26(4): p. 285-291.
10. Anwar, A., I.J. Anwar, and P. Delafontaine, Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs. Trends in cardiovascular medicine, 2015. 25(8): p. 726-735.
11. Woroń, J., et al., Irrational use of drugs as a source of drug-induced diseases. Medycyna wieku rozwojowego, 2007. 11(2 Pt 1): p. 87-91.
12. Wiliński, J., et al., Non-steroidal anti-inflammatory drugs and paracetamol in self-therapy of various disorders in students of different fields of study. Folia Medica Cracoviensia, 2015(2).
13. Jick, H., Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. The Lancet, 1994. 343(8900): p. 769-772.
14. Gray, B.A., et al., Gabapentin for perioperative pain management for uterine aspiration: a randomized controlled trial. Obstetrics and gynecology, 2019. 134(3): p. 611.
15. Liddy, N., et al., Opioid Requirement After Anterior Cruciate Ligament Surgery: Opioid Use After Anterior Cruciate Ligament Surgery Is Low With a Multimodal Approach, and Fifteen Oxycodone 5-mg Tablets Are Sufficient. Arthroscopy, Sports Medicine, and Rehabilitation, 2023. 5(2): p. e415-e421.
16. Farley, K.X., et al., Association between quantity of opioids prescribed after surgery or preoperative opioid use education with opioid consumption. Jama, 2019. 321(24): p. 2465-2467.
17. Davey, M.S., et al., Pain management strategies after anterior cruciate ligament reconstruction: A systematic review with network meta-analysis. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2021. 37(4): p. 1290-1300. e6.
18. Wyles, C.C., et al., Implementation of procedure-specific opioid guidelines: a readily employable strategy to improve consistency and decrease excessive prescribing following orthopaedic surgery. JBJS Open Access, 2020. 5(1).
19. Maneuf, Y., et al., Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cellular and Molecular Life Sciences CMLS, 2003. 60: p. 742-750.
20. BACKONJA, M., et al., Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Survey of Anesthesiology, 1999. 43(4): p. 236-237.
21. Serpell, M. and N.P.S. Group, Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain, 2002. 99(3): p. 557-566.
22. Di Benedetto, P., et al., Causes of failure of anterior cruciate ligament reconstruction and revision surgical strategies. Knee surgery & related research, 2016. 28(4): p. 319.
23. Jansson, H., S.J. Narvy, and N. Mehran, Perioperative pain management strategies for anterior cruciate ligament reconstruction. JBJS reviews, 2018. 6(3): p. e3.
24. Hajewski, C.J., et al., Impact of a standardized multimodal analgesia protocol on opioid prescriptions after common arthroscopic procedures. Orthopaedic journal of sports medicine, 2019. 7(9): p. 2325967119870753.
25. Shanmugaraj, A., et al., All-inside anterior cruciate ligament reconstruction—a systematic review of techniques, outcomes, and complications. The Journal of Knee Surgery, 2018. 31(09): p. 895-904.
26. Sayegh, E.T., et al., Defining the opioid requirement in anterior cruciate ligament reconstruction. JAAOS Global Research & Reviews, 2022. 6(1).
27. Beck, J.J., et al., Prospective study of acute opioid use after adolescent anterior cruciate ligament reconstruction shows no effect from patient-or surgical-related factors. JAAOS-Journal of the American Academy of Orthopaedic Surgeons, 2020. 28(7): p. 293-300.
28. Hah, J., et al., Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial. JAMA surgery, 2018. 153(4): p. 303-312.
29. Bang, S.R., S.K. Yu, and T.H. Kim, Can gabapentin help reduce postoperative pain in arthroscopic rotator cuff repair? A prospective, randomized, double-blind study. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2010. 26(9): p. S106-S111.
30. Li, Y., et al., Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis. European journal of medical research, 2021. 26: p. 1-11.